Related Experiment Video
Updated: May 14, 2026
07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Summary
Cancer carve-outs aim to improve care and control costs, but faced setbacks. With rising treatment expenses, these specialized care models are being reconsidered with new options available.
Area of Science:
- Health Services Research
- Oncology Management
- Healthcare Economics
Background:
- Cancer carve-outs were proposed a decade ago as a solution for enhancing patient care, managing treatment expenses, and distributing financial risks among payers.
- The initial adoption of cancer carve-outs was hindered by a significant backlash against managed care strategies.
- Current trends indicate a resurgence of interest in cancer carve-outs due to escalating cancer treatment costs.
Purpose of the Study:
- To analyze the historical context and renewed interest in cancer carve-outs.
- To explore the evolving landscape and current options for specialized cancer care models.
- To understand the factors driving the reconsideration of cancer carve-out strategies in contemporary healthcare.
Main Methods:
- Historical analysis of healthcare policy and market trends related to cancer care.
- Review of current healthcare economic factors influencing treatment delivery.
- Comparative assessment of past and present approaches to cancer care management.
Main Results:
- The initial implementation of cancer carve-outs faced significant challenges and stalled.
- Rising costs of cancer treatment have reignited discussions about specialized care models.
- The current environment presents different strategic choices and considerations for cancer carve-outs compared to a decade ago.
Conclusions:
- Cancer carve-outs represent a complex healthcare strategy with a history of both potential benefits and implementation hurdles.
- The escalating financial burden of cancer care necessitates a re-evaluation of innovative care delivery and risk-sharing models.
- The contemporary healthcare landscape offers distinct opportunities and challenges for the successful implementation of cancer carve-out programs.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:12What is Cancer?
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...